Tate & Lyle PLC
TATE: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| GBX 587.00 | Gkmfjx | Frhhvngm |
New Morningstar Analyst Report for Tate & Lyle PLC
Business Strategy and Outlook
Tate & Lyle is a play on secular growth trends such as the increasing use of ingredients in food and beverage to remove unhealthy components (sugar, fat, salt, sodium); reduce the cost of raw materials for manufacturers and increase shelf life of the product; and satisfy the increasing number of formulations being requested by manufacturers. The business is split into speciality (38% of sales, 64% of EBIT) and bulk (62% of sales, 36% of EBIT) ingredients.